Vaccines

12 Aug 2020 Vaccibody AS and Nektar Therapeutics Announce First Patient Dosed in a Phase 1/2a Study Arm Evaluating VB10.NEO, a Personalized Neoantigen Cancer Vaccine, with Bempegaldesleukin (NKTR-214) in Patients with Squamous Cell Carcinoma of the Head and Neck
11 Aug 2020 Arcturus Therapeutics Announces that it has Initiated Dosing of its COVID-19 STARR™ mRNA Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 study
10 Aug 2020 Vaxart Announces IND Filed for COVID-19 Vaccine
10 Aug 2020 GeneCure Biotechnologies launches first-in-human therapeutic vaccine to treat Covid-19 patients
10 Aug 2020 BIOQUAL Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of an mRNA Vaccine Against COVID-19 (mRNA-1273)
07 Aug 2020 Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan: Takeda
07 Aug 2020 Novavax and Serum Institute of India Announce Development and Commercial Collaboration
06 Aug 2020 IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study
06 Aug 2020 VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine Development
06 Aug 2020 Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
05 Aug 2020 BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
05 Aug 2020 Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
05 Aug 2020 Zydus Cadila Announces Completion of Dosing in Phase I Clinical Trial of ZyCoV-D
04 Aug 2020 DBV Technologies Receives Complete Response Letter from FDA for Viaskin Peanut BLA in Children Ages 4-11 Years
03 Aug 2020 ImmunityBio Study Shows Positive T Cell and Antibody Immune Responses to its COVID-19 Vaccine Candidate that Targets Both Spike and Nucleocapsid Virus Proteins
02 Aug 2020 Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate
31 Jul 2020 Sanofi and GSK selected for Operation Warp Speed to supply United States Government with 100 million doses of COVID-19 vaccine
31 Jul 2020 BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo® (cemiplimab) Combination in Melanoma
31 Jul 2020 Enterome initiates first clinical trial with EO2401 - an innovative microbiome-antigen ('OncoMimic') based cancer immunotherapy candidate targeting aggressive brain cancer
31 Jul 2020 INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus
30 Jul 2020 Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
29 Jul 2020 Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies
29 Jul 2020 Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
29 Jul 2020 Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine
29 Jul 2020 Clinical phase about to begin

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top